HOME >> MEDICINE >> NEWS
The lancet infectious diseases (TLID) October press release

Bacterial eradication in the treatment of otitis media

Otitis media (middle-ear infection) is a common infectious disease of early childhood; an estimated 20 million cases occur in the USA annually. This review assesses the impact of antibacterial treatment, commenting on how clinicians may become mislead by drug treatment as otitis media often resolves naturally within a few days of infection; the growing problem of widespread antibiotic resistance is also limiting the effectiveness of many therapeutic treatments for the disorder.

Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa?

This review calls for the re-introduction of strategies to target the larvael stage of the anopheles mosquito as part of the global 'Roll Back Malaria' campaign.

OTHER REVIEWS:

Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections

This systematic review and meta-analysis of randomised controlled trials involving more than 5000 women provides further evidence that a cheap and commonly used spermicide gel is not effective in reducing HIV-1 and other sexually transmitted infections.

Staphylococcus aureus disease in drug users
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
4-Oct-2002


Page: 1

Related medicine news :

1. The lancet specialty journals press releases
2. Physicians call for increased funding for federal infectious disease programs
3. Mailman School of Public Health researchers develop infectious disease diagnostic tool
4. Childrens Hospital Oakland opens new $5.6 million infectious disease lab
5. NIAID launches program to improve medical tools against emerging infectious diseases
6. Study suggests better use of web could improve infectious disease reporting
7. International public health expert Jeffrey Koplan addresses emerging infectious diseases conference
8. Two centres for infectious diseases established
9. Expert guide to infectious diseases published
10. Stress may increase susceptibility to infectious disease
11. First mouse model for multiple system atrophy points to new treatment targets for brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... 2017 , ... Immunotherapy has emerged as one of the most promising options ... be the next revolution in our fight against this complex disease. One of the ... checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education Resource® (PER®), ... medical education conference for clinicians who manage some of the most difficult-to-treat forms ... , The program will be led by co- chairs Dr. John Marshall, chief ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... VisualSP has ... sustainably. Until recently, the only option for on-premises installation of its Help System for ... required to install the system into the entire tenant. , The company recently ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as it ... either don’t have access to a health care facility or a pharmacy within 60 minutes ... the United States or for many who are faced with health or personal issues that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017  Medeon Biodesign, Inc., a ... is pleased to announce that the Company led ... Panther Orthopedics, Inc., a San Jose, ... solutions for orthopedic extremity applications.  ... rapidly, primarily due to procedure volume growth, lifestyle ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... 2017  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... fourth quarter and year ended December 31, 2016. ... progress for Orexigen, beginning with the re-acquisition of the ... March, the team at Orexigen demonstrated remarkable focus, executing ... and strengthened our Company while rewarding us full control ...
Breaking Medicine Technology:
Cached News: